NORTHERN TRUST CORP

Bank

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 73124 CHICAGO, IL

Position in ORMP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$889,464

+$848,048 QoQ

Shares Held

184,920

+1498.4% QoQ

Ownership

0.445%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 84 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 97% Shared 3% None 0%

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. ORMP ranks #279 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,486,478	$1,235,108,212
2	REGN	Regeneron Pharmaceuticals, Inc.	916,467	$571,453,829
3	ALNY	Alnylam Pharmaceuticals, Inc.	886,900	$266,983,504
4	RPRX	Royalty Pharma plc	4,718,859	$264,586,419
5	RVMD	Revolution Medicines, Inc.	1,117,110	$209,212,357
6	MRNA	Moderna, Inc.	2,985,329	$209,062,587
7	INCY	Incyte Corp	1,761,966	$199,736,460
8	CYTK	Cytokinetics Inc	1,647,345	$140,337,319

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$889,464	184,920	+1498.4%	Shares	Other	2026-08-13
2023-06-30	$41,416	11,569	0.0%	Shares	Defined	2023-08-11
2023-03-31	$25,219	11,569	-2.2%	Shares	Defined	2023-05-15
2022-12-31	$142,338	11,832	-15.0%	Shares	Defined	2023-02-13
2022-09-30	$90,233	13,925	+2.1%	Shares	Defined	2022-11-14
2022-06-30	$62,470	13,640	-95.2%	Shares	Defined	2022-08-12
2022-03-31	$2,442,569	282,378	+16.1%	Shares	Defined	2022-05-13
2021-12-31	$3,471,824	243,125	+7.7%	Shares	Defined	2022-02-08
2021-09-30	$4,963,765	225,831	+7.0%	Shares	Defined	2021-11-15
2021-06-30	$2,824,275	211,082	—	Shares	Defined	2021-08-13
No filing history on record for this holder in this stock.